Clinical Trial Update: A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MEDI-524 in children with hemodynamically significant congenital heart disease has completed. Results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• MEDI-524

Snippet

Sponsor: MedImmune LLC | Conditions: Congenital Heart Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-02-14